Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: Study of the Preventive Effects and Mechanisms of Yeast β-Glucan on Upper Respiratory Tract Infections [NA]

View source ↗

Summary

This clinical trial investigates whether yeast-derived beta-glucan can prevent upper respiratory tract infections and explores its mechanisms, and is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yeast β-Glucan (beta-glucan (yeast-derived))

Snippet

Sponsor: LanZhou University | Conditions: Upper Respiratory Tract Infections | NA | Status: NOT_YET_RECRUITING